| ||
Valeant Pharmaceuticals to buy OraPharma for $312 million domain-B Canadian specialty pharmaceutical company Valeant Pharmaceuticals International Inc today said it will buy privately held OraPharma from private equity firm ... See all stories on this topic » | ||
Valeant Pharmaceuticals Agrees To Acquire OraPharma MarketWatch (press release) Valeant Pharmaceuticals International, Inc. (nyse/tsx:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a ... See all stories on this topic » | ||
Ohr Pharmaceutical Announces Squalamine Eye Drop Presentation ... MarketWatch (press release) About Ohr Pharmaceutical Inc. Ohr Pharmaceutical Inc. (OBB:OHRP) ( www.ohrpharmaceutical.com ) is a pharmaceutical company dedicated to the clinical ... See all stories on this topic » | ||
China Nuokang Bio-Pharmaceutical Inc. Announces Change in CFO MarketWatch (press release) China Nuokang Bio-Pharmaceutical Inc. (NASDAQ:NKBP) is a leading biopharmaceutical company in China focused on the research, development, ... See all stories on this topic » | ||
Alembic settles patent case with Novartis for generic capsules Hindu Business Line Alembic Pharmaceuticals, on Friday said it along with US' Breckenridge Pharmaceutical Inc has settled patent case with Novartis for Rivastigmine Tartrate ... See all stories on this topic » | ||
Valeant Pharmaceuticals Completes Syndication Of Incremental ... Sacramento Bee PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today the successful syndication of $600 million of ... See all stories on this topic » | ||
| ||
Sunovion Pharmaceuticals Canada Inc. Announces Health Canada ... Sacramento Bee NDS Included 48 Clinical Studies Involving More Than 2900 Subjects Treated With Lurasidone. See all stories on this topic » | ||
Mergers and Acquisitions Activity Expected to Pick Up as a Result of ... MarketWatch (press release) Five Star Equities examines the outlook for companies in the Biotech Industry and provides equity research on BioSante Pharmaceuticals Inc. (NASDAQ:BPAX) ... See all stories on this topic » | ||
Dalton Pharma Services and Clarity Pharmaceuticals Enter Into ... San Francisco Chronicle (press release) Dalton will provide cGMP chemistry manufacturing, scale up, aseptic fill/finish services and analytical support for Clarity Toronto, Ontario (PRWEB) June 14, ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment